Company: BIVIW
Filing Date: 2025-05-12
Form Type: 10-Q
Source: 0001520138-25-000144
Chunk: 3

Company: BIOVIE INC.
Filing Date: 2025-05-12
Form: 10-Q
Item: Part I, Item 1
Chunk 3
---
 Other comprehensive loss 

    Reclassification of unrealized gains on available-for-sale investments upon settlement 
     -  
     -  
     -  
     (176,591)
  
    Total other comprehensive loss 
     -  
     -  
     -  
     (176,591)
  
    Comprehensive loss 
    $(2,788,418) 
    $(8,954,253) 
    $(14,422,444) 
    $(28,242,753)

See accompanying notes to unaudited condensed financial
statements

 5 

Table of Contents 

BioVie Inc.

Condensed Statements of Changes in Stockholders’
Equity 

(Unaudited)

    Accumulated  

    Common  
    Common  
    Additional  
    Treasury  
    Treasury  
    Other  
       
    Total 

     Stock  
     Stock  
    Paid in  
     Stock  
     Stock  
    Comprehensive  
    Accumulated  
    Stockholders' 

    Shares  
    Amount  
    Capital  
    Shares  
    Amount  
    Income  
    Deficit  
    Equity 

    Balance, June 30, 2023 
     3,645,183  
    $3,643  
    $316,385,759  
     (2,288) 
    $(2) 
    $176,591  
    $(301,225,705) 
    $15,340,286 

    Stock-based compensation - stock options 
     -  
     -  
     808,027  
     -  
     -  
     -  
     -  
     808,027 

    Stock-based compensation - restricted stock units 
     -  
     -  
     380,834  
     -  
     -  
     -  
     -  
     380,834 

    Proceeds from issuance of common stock, net of costs of  $118,891 
     43,220  
     43  
     1,905,793  
     -  
     -  
     -  
     -  
     1,905,836 

    Issu